How CAR-T Cell Therapy is Impacting Solid Tumor Cancer Research

By David Haas
Wednesday June 5, 2019

Treatment options available to cancer patients have both improved and grown over the past decade. The development of personalized medicine has enabled patients to seek a new route, tailoring their treatments specifically to their situations. One outcome of this unique treatment approach is the development of CAR-T (chimeric antigen receptor T) cell therapy (see: Taking Personalized Medicine to a New Level: CAR-T Cell Therapy). Continue reading “How CAR-T Cell Therapy is Impacting Solid Tumor Cancer Research”